Anna Hester
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Breast Cancer Treatment Studies
Papers in
-
- Ovarian cancer diagnosis and treatment 14
-
- Galectins and Cancer Biology 2
- Co-authors
- Udo Jeschke (32 shared papers)Sven� Mahner (31 shared papers)Bastian Czogalla (25 shared papers)Thomas Kolben (26 shared papers)Elisa Schmoeckel (23 shared papers)Fabian Trillsch (22 shared papers)Doris Cooper Mayr (22 shared papers)Christina Kühn (14 shared papers)
In The Last Decade
Anna Hester
41 papers receiving 529 citations
Peers
Comparison fields: 5 of 63
- Reproductive Medicine 71
- Cancer Research 74
- Immunology 89
- Oncology 73
- Obstetrics and Gynecology 30
Countries citing papers authored by Anna Hester
This map shows the geographic impact of Anna Hester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Hester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Hester more than expected).
Fields of papers citing papers by Anna Hester
This network shows the impact of papers produced by Anna Hester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Hester. The network helps show where Anna Hester may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Hester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 41 | |
| 2 | 2023 | 38 | |
| 3 | 2020 | 34 | |
| 4 | 2020 | 27 | |
| 5 | 2021 | 27 | |
| 6 | 2020 | 26 | |
| 7 | 2019 | 23 | |
| 8 | 2020 | 22 | |
| 9 | 2021 | 20 | |
| 10 | 2020 | 18 | |
| 11 | 2021 | 16 | |
| 12 | 2019 | 15 | |
| 13 | 2022 | 15 | |
| 14 | 2019 | 14 | |
| 15 | 2022 | 12 | |
| 16 | 2019 | 11 | |
| 17 | 2020 | 11 | |
| 18 | 2021 | 11 | |
| 19 | 2021 | 10 | |
| 20 | 2021 | 10 |
About Anna Hester
Anna Hester is a scholar working on Reproductive Medicine, Immunology, Obstetrics and Gynecology, Pharmacology and Geriatrics and Gerontology, having authored 41 papers that have together received 534 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (14 papers), Inflammatory mediators and NSAID effects (4 papers), Cervical Cancer and HPV Research (3 papers), BRCA gene mutations in cancer (3 papers), Epigenetics and DNA Methylation (2 papers), Galectins and Cancer Biology (2 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Reproductive Medicine (71 citations), Cancer Research (74 citations), Immunology (89 citations), Oncology (73 citations) and Obstetrics and Gynecology (30 citations). Anna Hester has collaborated with scholars based in Germany and China. Frequent co-authors include Udo Jeschke, Sven� Mahner, Bastian Czogalla, Thomas Kolben, Elisa Schmoeckel, Fabian Trillsch, Doris Cooper Mayr, Christina Kühn, Alexander Burges and Susanne Beyer. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Cancer Research and Clinical Oncology, Histochemistry and Cell Biology, Cells and Breast Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.